Construction Manager As Constructor (CMC) services for the new Food and Drug Administration (FDA) laboratory at building 22, Denver federal center, la

Only one company submitted a bid. Reduced competition may indicate barriers to entry, poor solicitation visibility, or pre-determined outcomes.

This contract has unrealized obligation backlog — funds committed but work not yet performed. This can indicate project delays or budget holds.

Post-award modifications total 200% of the original award. Change orders exceeding 50% suggest scope creep, poor initial estimates, or intentional low-bidding.

Contract duration is 2.9 standard deviations above the average for similar contracts. Unusually long or short durations may indicate scope issues.